Significant Improvement in Detecting BRAF, KRAS, and EGFR Mutations Using Next-Generation Sequencing as Compared with FDA-Cleared Kits
Crossref DOI link: https://doi.org/10.1007/s40291-017-0290-z
Published Online: 2017-06-21
Published Print: 2017-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ma, Wanlong
Brodie, Steven
Agersborg, Sally
Funari, Vincent A.
Albitar, Maher http://orcid.org/0000-0001-7661-9537
Funding for this research was provided by:
NeoGenomicsLaboratories
License valid from 2017-06-21